Clopidogrel response: Head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting

被引:44
作者
Cuisset, Thomas [1 ,2 ]
Frere, Corinne [2 ,3 ]
Poyet, Raphael [1 ]
Quilici, Jacques [1 ]
Gaborit, Benedicte [2 ,3 ]
Bali, Laurent [1 ]
Brissy, Olivier [1 ]
Lambert, Marc [1 ]
Morange, Pierre-Emmanuel [2 ,3 ]
Alessi, Marie-Christine [2 ,3 ]
Bonnet, Jean-Louis [1 ]
机构
[1] CHU Timone, Dept Cardiol, Marseille, France
[2] CHU Timone, Fac Med, INSERM, UMR 626, F-13385 Marseille, France
[3] CHU Timone, Hematol Lab, F-13385 Marseille, France
关键词
Acute coronary syndromes; Stenting; Clopidogrel response; Platelet function testing; OF-CARE ASSAY; ADVERSE CARDIOVASCULAR EVENTS; DUAL ANTIPLATELET THERAPY; CLINICAL-OUTCOMES; REACTIVITY; PHOSPHORYLATION; RESPONSIVENESS; AGGREGATION; INHIBITION; RESISTANCE;
D O I
10.1016/j.acvd.2009.11.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. - We investigated the agreement between different platelet tests to identify clopidogrel non response. Background. - Biological definition of clopidogrel non response remains controversial. Different platelet tests have been linked with recurrent ischemic events and proposed for daily practice. Methods. - We prospectively investigated the agreement of platelet tests to isolate clopidogrel non response in patients receiving high 150 mg clopidogrel maintenance dose after coronary stenting. Clopidogrel. response was assessed with ADP-induced aggregation (ADP-Ag) (non response if > 70%), Platelet reactivity index VASP (PRI VASP) (non response if > 50%) and Verify Now Point-of-care assay (VN) (non response if PRU > 240 AU). Results. - Seventy consecutive patients were included. The rates of non-responders were respectively: 13% (n = 9) with the ADP-Ag, 39% (n = 27) with the PRI VASP and 33% (n = 23) with the VN. We observed significant correlation between different platelet tests assessing clopidogrel response: r = 0.55 (p < 0.0001) for ADP-Ag and PRI VASP, r = 0.64 (p < 0.0001) for ADP-Ag and VN and r = 0.59 (p < 0.0001) for PRI VASP and VN. However, using the most common thresholds, the agreement between the difference tests was poor: 0.35 for ADP-Ag and PRI VASP, 0.36 for ADP-Ag and VN and 0.46 for PRI VASP and VN. Conclusion. - This study showed that assessment of platelet function inhibition by clopidogrel is highly test-specific. Indeed, our results demonstrated a poor agreement between different platelet assays and suggested that identification of clopidogrel non responders is test-dependent. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 50 条
[41]   Effects of Endothelial Dysfunction on Residual Platelet Aggregability After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease [J].
Fujisue, Koichiro ;
Sugiyama, Seigo ;
Ono, Takamichi ;
Matsuzawa, Yasushi ;
Akiyama, Eiichi ;
Sugamura, Koichi ;
Matsubara, Junichi ;
Kurokawa, Hirofumi ;
Kaikita, Koichi ;
Iwashita, Satomi ;
Sumida, Hitoshi ;
Hokimoto, Seiji ;
Oniki, Kentaro ;
Nakagawa, Kazuko ;
Matsui, Kunihiko ;
Ogawa, Hisao .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (04) :452-459
[42]   Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention [J].
Mangiacapra, Fabio ;
Patti, Giuseppe ;
Peace, Aaron ;
Gatto, Laura ;
Vizzi, Vincenzo ;
Ricottini, Elisabetta ;
D'Ambrosio, Andrea ;
Muller, Olivier ;
Barbato, Emanuele ;
Di Sciascio, Germano .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (05) :619-623
[43]   Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting [J].
De Luca, G ;
Suryapranata, H ;
van't Hof, AWJ ;
Ottervanger, JP ;
Hoorntje, JCA ;
Gosselink, ATM ;
Damibrink, JHE ;
Zijlstra, F ;
Boer, MJC .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (06) :1084-1089
[44]   Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Japanese Patients With Stable Coronary Artery Disease [J].
Nishi, Takeshi ;
Ariyoshi, Noritaka ;
Nakayama, Takashi ;
Fujimoto, Yoshihide ;
Sugimoto, Kazumasa ;
Takahara, Masayuki ;
Wakabayashi, Shinichi ;
Koshizaka, Masaya ;
Hanaoka, Hideki ;
Kobayashi, Yoshio .
CIRCULATION JOURNAL, 2015, 79 (11) :2439-2444
[45]   High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel [J].
Siasos, Gerasimos ;
Oikonomou, Evangelos ;
Zaromitidou, Marina ;
Kioufis, Stamatios ;
Vavuranakis, Manolis ;
Maniatis, Konstantinos ;
Kokkou, Eleni ;
Papageorgiou, Nikolaos ;
Papaioannou, Spyridon ;
Tourikis, Panagiotis ;
Papavassiliou, Athanasios G. ;
Stefanadis, Christodoulos ;
Tousoulis, Dimitris .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) :192-196
[46]   Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy [J].
Cuisset, Thomas ;
Gaborit, Benedicte ;
Dubois, Noemie ;
Quilici, Jacques ;
Loosveld, Marie ;
Beguin, Shirley ;
Loundou, Anderson Diendonne ;
Moro, Pierre Julien ;
Morange, Pierre Emmanuel ;
Alessi, Marie-Christine ;
Dutour, Anne ;
Bonnet, Jean-Louis .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) :523-528
[47]   A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: The CLO-CLO trial [J].
Oberhaensli, Markus ;
Lehner, Cedric ;
Puricel, Serban ;
Lehmann, Sonja ;
Togni, Mario ;
Stauffer, Jean-Christophe ;
Baeriswyl, Gerard ;
Goy, Jean-Jacques ;
Cook, Stephane .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2012, 105 (11) :587-592
[48]   Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification [J].
Li, Xiaoying ;
Qiu, Miaohan ;
Na, Kun ;
Li, Yuzhuo ;
Ma, Sicong ;
Qi, Zizhao ;
Li, Jing ;
Li, Yi ;
Han, Yaling .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 :1032-1039
[49]   Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients [J].
Paniccia, Rita ;
Antonucci, Emilia ;
Maggini, Niccolo ;
Miranda, Marco ;
Gori, Anna Maria ;
Marcucci, Rossella ;
Giusti, Betti ;
Balzi, Daniela ;
Prisco, Domenico ;
Abbate, Rosanna .
THROMBOSIS AND HAEMOSTASIS, 2010, 104 (02) :287-292
[50]   Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes [J].
Solinas, Emilia ;
Gobbi, Giuliana ;
Dangas, George ;
Mehran, Roxana ;
Fahy, Martin ;
Ippolito, Luigi ;
Bolognesi, Maria Giulia ;
Ruenes, Ruben ;
Merlini, Piera Angelica ;
Ardissino, Diego ;
Vitale, Marco .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 27 (01) :36-43